A detailed history of Gsa Capital Partners LLP transactions in Alector, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 63,583 shares of ALEC stock, worth $275,950. This represents 0.03% of its overall portfolio holdings.

Number of Shares
63,583
Holding current value
$275,950
% of portfolio
0.03%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$5.69 - $8.08 $361,787 - $513,750
63,583 New
63,583 $382,000
Q3 2022

Nov 14, 2022

BUY
$8.19 - $13.2 $114,619 - $184,734
13,995 New
13,995 $132,000
Q2 2022

Aug 09, 2022

SELL
$7.65 - $14.24 $99,327 - $184,892
-12,984 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$13.02 - $20.78 $169,051 - $269,807
12,984 New
12,984 $185,000
Q4 2021

Feb 14, 2022

SELL
$19.35 - $25.54 $1 Million - $1.32 Million
-51,730 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$21.65 - $39.49 $534,819 - $975,521
24,703 Added 91.4%
51,730 $1.18 Million
Q2 2021

Aug 05, 2021

BUY
$15.5 - $22.48 $418,918 - $607,566
27,027 New
27,027 $563,000
Q4 2020

Feb 03, 2021

SELL
$9.4 - $16.7 $98,418 - $174,849
-10,470 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$10.54 - $24.96 $110,353 - $261,331
10,470 New
10,470 $110,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $358M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.